CIK: 0001193586 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $365,065 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCTY | Paylocity Holding Corporation | 593,200 | $143,305 | 39.3% | $27.51 | +735.3% | Common | 70438V106 |
| RMNI | Rimini Street, Inc. | 23,565,433 | $109,815 | 30.1% | $8.44 | -33.6% | Common | 76674Q107 |
| — | Vacasa, Inc. | 16,527,901 | $50,741 | 13.9% | $7.49 | — | Common- Class A | 91854V107 |
| QTWO | Q2 Holdings, Inc. | 777,562 | $25,037 | 6.9% | $19.72 | +106.6% | Common | 74736L109 |
| — | Icosavax, Inc. | 3,392,392 | $10,720 | 2.9% | $26.63 | — | Common | 45114M109 |
| — | Fusion Pharmaceuticals, Inc. | 2,947,809 | $8,873 | 2.4% | $15.72 | — | Common | 36118A100 |
| PDD | Pinduoduo, Inc. | 100,926 | $6,316 | 1.7% | $62.58 | — | ADS | 722304102 |
| GTLB | GitLab, Inc. | 83,121 | $4,257 | 1.2% | $58.37 | 0.0% | Common Class A | 37637K108 |
| CRVS | Corvus Pharmaceuticals, Inc. | 3,275,616 | $2,683 | 0.7% | $13.47 | -92.9% | Common | 221015100 |
| — | Aptinyx, Inc. | 5,395,996 | $1,997 | 0.5% | $16.86 | — | Common | 03836N103 |
| XPEV | Xpeng, Inc | 52,766 | $631 | 0.2% | $11.96 | — | ADS | 98422D105 |
| WMS | Advanced Drainage Systems, Inc. | 2,884 | $359 | 0.1% | $101.05 | +21.2% | Common | 00790R104 |
| HCAT | Health Catalyst, Inc. | 34,157 | $331 | 0.1% | $28.37 | -53.3% | Common | 42225T107 |